Significance of monitoring vascular endothelial growth factor, monocyte chemoattractant protein-1 and Interleukin-8 in diabetic macular edema towards early identification of nonresponders to ranibizumab therapy

PURPOSE: Identification of nonresponders prior to anti-vascular endothelial growth factor (anti-VEGF) therapy would help in the judicious clinical management of diabetic macular edema (DME) patients. Thus, a systematic study was initiated to identify nonresponding DME patient population undergoing r...

Descripción completa

Detalles Bibliográficos
Autores principales: Xavier, Tessy, Pallikara, Swetha, Saji, Neha, Radhakrishnan, Natasha, Menon, Krishnakumar N, Pillai, Gopal S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302316/
https://www.ncbi.nlm.nih.gov/pubmed/34011723
http://dx.doi.org/10.4103/ijo.IJO_3109_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302316/
https://www.ncbi.nlm.nih.gov/pubmed/34011723
http://dx.doi.org/10.4103/ijo.IJO_3109_20

Ejemplares similares